$ARMAQ GMR Data concluded that the cancer-treatmen
Post# of 17844
Posted On: 02/10/2014 1:03:24 PM
$ARMAQ GMR Data concluded that the cancer-treatment industry has sales upwards to $77.4 billion annually, and that is expected to grow to $143.7 billion by 2023, which means the interferon market for AMARQ has great potential.
(0)
(0)Scroll down for more posts ▼